RINT1
protein-codingRAD50 interactor 1, the group of NRZ tethering complex
Gene summary
This gene encodes a protein first identified for its ability to interact with the RAD50 double strand break repair protein, with the resulting interaction implicated in the regulation of cell cycle progression and telomere length. The encoded protein may also play a role in trafficking of cellular cargo from the endosome to the trans-Golgi network. Mutations in this gene may be associated with breast cancer in human patients. [provided by RefSeq, Oct 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~35.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032844
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0032844
Submitter: Ambry Genetics
Inheritance Pattern: Unknown
Disease ID:MONDO:0016248
Submitter: ClinGen
Inheritance Pattern: AR
Disease ID:MONDO:0032844
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007254
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0019064
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014659
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0032844
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0016419
Submitter: ClinGen
RINT1 (RAD50 Interactor 1) encodes a protein first identified for its ability to interact with the RAD50 double strand break repair protein, with the resulting interaction implicated in the regulation of cell cycle progression and telomere length. RINT1 also plays a role in trafficking of cellular cargo from the endosome to the trans-Golgi network. Biallelic RINT1 mutations are associated with Infantile liver failure syndrome 3. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we describe curation for hereditary breast cancer (refute the association with breast cancer) in this curation. Evidence refuting this gene-disease relationship includes case-control data, while experimental data supports the role of RINT1 in cell cycle regulation. **Summary of Case-Control Data: 0.5 POINTS** This gene-disease relationship has been studied in at least 5 case-control studies at the aggregate variant level. In 2021, two large case-control studies [CARRIERS (PMID: 33471974) and BCAC (PMID: 33471991); both with more than 32 thousand cases and controls] did not identify a significant association of aggregate loss of function (LOF) variants in RINT1 and breast cancer. Likewise, two more case-control studies with smaller case and control sizes did not find significant association of breast cancer with pathogenic RINT1 variant (PMID:35884425) and missense RINT1 variants (PMID:27544226). However, a case-control study with small population size including 29 missense and 2 in-frame deletion RINT1 variants showed significant associations to breast cancer (0.5 points, PMID: 25050558). **Summary of Experimental Data: 3 POINTS** While major case-control studies did not support the gene-disease association, experimental data reported the physical interaction of RINT1 and RAD50, which further regulate cell cycle (0.5 points, PMID:11096100). Rint1-deficient fibroblasts showed a significant increase in chromosomal aberrations such as sister chromatid fusion (0.5 points, PMID:26383973). Rint-1 heterozygous mice also developed mammary gland adenocarcinoma (2 points, PMID:17470549). **Overall Summary:** In summary, given the lack of significant association in large breast cancer case-control studies to date, there is convincing evidence refuting the association between RINT1 and autosomal dominant hereditary breast cancer, which significantly outweighs the evidence supporting the association. This gene-disease pair was originally evaluated as disputed by the Breast/Ovarian Cancer GCEP on 9/26/2016. This re-curation was approved by the ClinGen Hereditary Diseases GCEP on 2/17/2023 (SOP Version 9).
Clinical Genomic Database (CGD)
Manifestation: Gastrointestinal; Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Liver transplant has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RINT1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_021930.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 11 | 457 | 5 | 473 | ||
| missense | 1 | 1 | 1110 | 58 | 2 | 1172 |
| nonsense | 8 | 7 | 13 | 28 | ||
| start loss | 0 | |||||
| frameshift | 14 | 13 | 22 | 49 | ||
| splice donor/acceptor (+/-2bp) | 2 | 15 | 11 | 28 | ||
| Total | 25 | 36 | 1167 | 515 | 7 | 1750 |
Highest pathogenic variant AF is 0.000019209177
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_068749.3 | 15 | MANE Select | |
| Ensembl | ENSP00000257700.2 | 15 | MANE Select | |
| RefSeq | NP_001333528.1 | 13 | Standard | |
| RefSeq | NP_001333529.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Vesicle-mediated transport
- Membrane Trafficking
- COPI-dependent Golgi-to-ER retrograde traffic
- Golgi-to-ER retrograde transport
- Intra-Golgi and retrograde Golgi-to-ER traffic
Biological Process
- retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
- Golgi organization
- cell cycle
- protein transport
- regulation of ER to Golgi vesicle-mediated transport
Molecular Function
- protein binding
Cellular Component
- endoplasmic reticulum
- endoplasmic reticulum membrane
- cytosol
- Dsl1/NZR complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000257700
- Coding exons
- 15
- Length
- 35593
- Individuals with no LoFs
- 125646
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 102
- Defined
- 125748
- p
- 0.000406
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.825 | 363 | 410 | 0.885 | 0.0000204 | 5203 |
| Missense (PolyPhen) | 81 | 110.69 | 0.73174 | 1499 | ||
| Synonymous | -0.485 | 158 | 150 | 1.05 | 0.00000786 | 1479 |
| Loss of Function | 2.49 | 27 | 45.1 | 0.599 | 0.00000250 | 507 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00051 | 0.00049 | rare |
| Latino/Admixed American | 0.00027 | 0.00026 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00054 | 0.00054 | rare |
| Finnish | 0.00018 | 0.00018 | rare |
| European (Non-Finnish) | 0.00051 | 0.00051 | rare |
| South Asian | 0.00033 | 0.00033 | rare |
| Other | 0.00051 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in regulation of membrane traffic between the Golgi and the endoplasmic reticulum (ER); the function is proposed to depend on its association in the NRZ complex which is believed to play a role in SNARE assembly at the ER. May play a role in cell cycle checkpoint control (PubMed:11096100). Essential for telomere length control (PubMed:16600870). {ECO:0000269|PubMed:11096100, ECO:0000269|PubMed:16600870, ECO:0000305}.;
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- LoFtool
- 0.836
- RVIS EVS
- -0.31
- RVIS percentile EVS
- 32.15
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.894
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |